Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study
- PMID: 22233756
- PMCID: PMC3269351
- DOI: 10.1186/1748-717X-7-2
Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study
Abstract
Purpose: To evaluate the clinical outcomes and patterns of failure in patients with nasopharyngeal carcinoma (NPC) treated with intensity modulated radiotherapy (IMRT) in Northwest China.
Methods and materials: From January 2006 to December 2009, 138 NPC patients were treated at Xijing Hospital. Of them, 25 cases with stage I-II received IMRT only, 113 cases with stage III-IVb received IMRT plus accomplished platinum-based chemotherapy. The IMRT prescribed dose was PTV 68-74 Gy to gross disease in nasopharynx and 66-72 Gy to positive lymph nodes in 30-33 fractions, and high risk and low risk region PTV was 60-63 Gy and 50.4~56 Gy in 30~33 and 28 fractions respectively. Plasma Epstein Barr virus (EBV) DNA load was measured before treatment. The clinical toxicities, outcomes and patterns of failure were observed.
Results: The median follow up time was 23 months (range 2 to 53 months). EBV infection positive was only 15.9%. Overall disease failure developed in 36 patients, 99% belonged to stage III/IV disease. Among these, there were 26 distant metastases, 6 local recurrence, and 4 regional recurrence. The 3-year local control rate(LCR), distant metastasis-free survival (MFS), disease-free survival (DFS) and the overall survival (OS) was 93.9%, 79.5%, 70% and 83.1% respectively. Multivariate analyses revealed that age and anemia pre-radiotherapy were independent predictors for OS.
Conclusion: IMRT with or without chemotherapy can improve the long term survival of NPC patients in Northwest China. Distant metastasis becomes the main cause of treatment failure. Age and anemia before radiotherapy were the main prognosis factors of NPC patients.
Figures



Similar articles
-
Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.J Cancer Res Ther. 2015 Oct;11 Suppl 2:C179-84. doi: 10.4103/0973-1482.168181. J Cancer Res Ther. 2015. PMID: 26506872
-
Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.PLoS One. 2016 Apr 27;11(4):e0154501. doi: 10.1371/journal.pone.0154501. eCollection 2016. PLoS One. 2016. PMID: 27119991 Free PMC article.
-
Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.Chin J Cancer. 2010 Feb;29(2):145-50. doi: 10.5732/cjc.009.10332. Chin J Cancer. 2010. PMID: 20109341
-
Advanced Nasopharyngeal Carcinoma: Current and Emerging Treatment Options.Cancer Manag Res. 2022 Sep 12;14:2681-2689. doi: 10.2147/CMAR.S341472. eCollection 2022. Cancer Manag Res. 2022. PMID: 36117730 Free PMC article. Review.
-
Nasopharyngeal carcinoma in young patients: a systematic review of racial demographics.Laryngoscope. 2006 Jun;116(6):1021-6. doi: 10.1097/01.mlg.0000217243.08756.0c. Laryngoscope. 2006. PMID: 16735924
Cited by
-
Twist1 promotes radioresistance in nasopharyngeal carcinoma.Oncotarget. 2016 Dec 6;7(49):81332-81340. doi: 10.18632/oncotarget.12875. Oncotarget. 2016. PMID: 27793033 Free PMC article.
-
Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis.Med Oncol. 2014 Dec;31(12):330. doi: 10.1007/s12032-014-0330-z. Epub 2014 Nov 22. Med Oncol. 2014. PMID: 25416046
-
Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.J Cancer Res Clin Oncol. 2020 Sep;146(9):2369-2378. doi: 10.1007/s00432-020-03229-3. Epub 2020 May 3. J Cancer Res Clin Oncol. 2020. PMID: 32363479 Free PMC article.
-
Analysis of Clinical Target Volume Delineation in Local-regional Failure of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy.J Cancer. 2020 Jan 29;11(7):1968-1975. doi: 10.7150/jca.39588. eCollection 2020. J Cancer. 2020. PMID: 32194808 Free PMC article.
-
Patterns of local failures and suggestions for reduction of clinical target volume for nasopharyngeal carcinoma patients without cervical lymph node metastasis.Onco Targets Ther. 2018 May 7;11:2545-2555. doi: 10.2147/OTT.S158126. eCollection 2018. Onco Targets Ther. 2018. PMID: 29765233 Free PMC article.
References
-
- Zhang L, Zhao C, Ghimire B, Hong MH, Liu Q, Zhang Y, Guo Y, Huang YJ, Guan ZZ. The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase iii randomized trials. BMC Cancer. 2010;10:558. doi: 10.1186/1471-2407-10-558. - DOI - PMC - PubMed
-
- Teo P, Yu P, Lee WY, Leung SF, Kwan WH, Yu KH, Choi P, Johnson PJ. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys. 1996;36(2):291–304. doi: 10.1016/S0360-3016(96)00323-9. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources